Last --
Change Today 0.00 / 0.00%
Volume 0.0
600196 On Other Exchanges
600196 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shanghai fosun pharmaceuti-a (600196) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI FOSUN PHARMACEUTI-A (600196)

Related News

No related news articles were found.

shanghai fosun pharmaceuti-a (600196) Related Businessweek News

No Related Businessweek News Found

shanghai fosun pharmaceuti-a (600196) Details

Shanghai Fosun Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, is engaged in the research and development, manufacture, distribution, and retail sale of pharmaceutical products in Mainland China and internationally. The company offers metabolism and alimentary tract drugs for the treatment of chronic hepatitis B, diabetes, chronic atrophic gastritis and gastralgia, flatulence, anorexia, eructation, and pyrosis; and anti-infection drugs to treat malaria, cefmetazole sodium sensitive bacterial infections, tuberculosis, sensitive gram-positive bacterial infections, and viral pneumonia and upper respiratory tract infections. It also provides cardiovascular and blood system drugs for antithrombotic treatment, ductus dependent congenital heart diseases, hypoxaemia relief, and chronic hepatitis; and the treatment of myocarditis, sinus syndrome, coronary heart disease, cardiomyopathy, arrhythmia, hypertension, microangiopathy, varicose veins syndrome, microcirculatory disorders, hypercholesterolemia, anemia, and chronic renal failure, as well for various dialysis treatments. In addition, the company offers oncology drugs for the treatment of lung, breast, prostate, gastric, colorectal, and nasopharyngeal cancers, as well as malignant pleural mesothelioma; and vaccines for the prevention of influenza. Further, it provides central nervous system drugs; and crude drugs and intermediates. Additionally, the company develops, manufactures, sells, imports, and exports medical equipment; provides healthcare and hospital management services, and consulting services; and manufactures and sells biologic pharmaceutical products. It operates approximately 650 retail pharmacies under For Me Pharmacy and Golden Elephant Pharmacy brands. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China.

16,791 Employees
Last Reported Date: 03/24/14
Founded in 1994

shanghai fosun pharmaceuti-a (600196) Top Compensated Officers

Vice Chairman, Chief Executive Officer, Presi...
Total Annual Compensation: CNY5.0M
Executive Chairman and Chairman of Strategic ...
Total Annual Compensation: CNY6.8M
Compensation as of Fiscal Year 2013.

shanghai fosun pharmaceuti-a (600196) Key Developments

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Approves Amendments to the Articles of Association

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that the 42nd special session of the 6th directorate meeting held on February 12, 2015, approved the amendments to the Articles of Association.

Shanghai FOSUN Pharmaceutical (Group) Co., Ltd., Board Meeting, Feb 12, 2015

Shanghai FOSUN Pharmaceutical (Group) Co., Ltd., Board Meeting, Feb 12, 2015. Agenda: To discuss and approve the proposal of amending Articles of Association.

Shanghai FOSUN Pharmaceutical (Group) Co., Ltd., Board Meeting, Jan 19, 2015

Shanghai FOSUN Pharmaceutical (Group) Co., Ltd., Board Meeting, Jan 19, 2015. Agenda: To discuss and approve issues including the proposal of repurchasing and canceling some restricted A shares having not been unlocked; to approve the proposal of unlocking phase I restricted A shares; and to approve the proposal of changing registered capital.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600196:CH CNY22.65 CNY -0.03

600196 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bumrungrad Hospital PCL 155.50 THB +0.50
Fortis Healthcare Ltd 162.15 INR +1.30
IHH Healthcare Bhd 5.57 MYR +0.09
KPJ Healthcare Bhd 4.00 MYR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 600196 Industry Range
Price/Earnings 18.9x
Price/Sales 4.4x
Price/Book 3.1x
Price/Cash Flow 16.0x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI FOSUN PHARMACEUTI-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at